-+ 0.00%
-+ 0.00%
-+ 0.00%

TNF Pharma Announces 1-For-100 Reverse Stock Split Effective Sept. 2; Operational Updates Expected Post-Split

Benzinga·08/28/2025 13:20:45
Listen to the news

TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, today announced that its board of directors has authorized a reverse stock split of the Company's common stock at a ratio of 1 post-split share for every 100 pre-split shares.

The Company's common stock will begin trading on a split-adjusted basis upon market open on Tuesday, September 2, 2025. The Company expects to provide operational business updates coinciding with the completion of the reverse stock split.